JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M208661200 on February 3, 2003

J. Biol. Chem., Vol. 278, Issue 18, 16073-16081, May 2, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/18/16073    most recent
M208661200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, M.-C.
Right arrow Articles by Hsieh, S.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, M.-C.
Right arrow Articles by Hsieh, S.-L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Role of Apoptosis Signal-regulating Kinase 1 in Lymphotoxin-beta Receptor-mediated Cell Death*

Mei-Chieh Chenab, Ming-Jing Hwangc, Yang-Chieh Choua, Wei-Hsu Chencd, Genhong Chenge, Hiroyasu Nakanofk, Tien-Yau Luhg, Shen-Chih Maiah, and Shie-Liang Hsiehaij

From the a Institute and Department of Microbiology and Immunology, National Yang-Ming University, Taipei 11221, Taiwan, the c Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, the i Immunology Research Center, National Yang-Ming University, Taipei 11221, Taiwan, the e Department of Microbiology, Immunology, and Molecular Genetics, Jonsson Comprehensive Cancer Center and Molecular Biology Institute, UCLA, Los Angeles, California 90095, the f Department of Immunology, Juntendo University School of Medicine, Tokyo 113, Japan, and the g Department of Chemistry, National Taiwan University, Taipei 106, Taiwan

LIGHT (homologous to lymphotoxins, shows inducible expression, and competes with herpes simplex virus glycoprotein D for herpesvirus entry mediator, a receptor expressed by T lymphocytes) is a member of the tumor necrosis factor superfamily that can interact with lymphotoxin-beta receptor (LTbeta R), herpes virus entry mediator, and decoy receptor (DcR3). In our previous study, we showed that LIGHT is able to induce cell death via the non-death domain containing receptor LTbeta R to activate both caspase-dependent and caspase-independent pathway. In this study, a LIGHT mutein, LIGHT-R228E, was shown to exhibit similar binding specificity as wild type LIGHT to LTbeta R, but lose the ability to interact with herpes virus entry mediator. By using both LIGHT-R228E and agonistic anti-LTbeta R monoclonal antibody, we found that signaling triggered by LTbeta R alone is sufficient to activate both caspase-dependent and caspase-independent pathways. Cross-linking of LTbeta R is able to recruit TRAF3 and TRAF5 to activate ASK1, whereas its activity is inhibited by free radical scavenger carboxyfullerenes. The activation of ASK1 is independent of caspase-3 activation, and kinase-inactive ASK1-KE mutant can inhibit LTbeta R-mediated cell death. This suggests that ASK1 is one of the factors involved in the caspase-independent pathway of LTbeta R-induced cell death.


* This work was mainly supported by National Science Council, Taiwan, Grants NSC 91-2320-B-010-053, NSC 91-2320-B010-092. Additional support came from the National Health Research Institute, Taiwan (NHRI-CN-BP-8902S) and the Ministry of Education (89-B-FA22-2-4) under the Program for Promoting Academic Excellence of Universities. This work was also supported by Chi-Mei Foundational Hospital, Tainan, Grant CMYM 8902.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

b Present address: Dept. of Microbiology and Immunology, Taipei Medical University, Taipei 110, Taiwan.

d Present address: United Biomedical, Inc., New York, NY 11788.

h Present address: Anawrahta Biotechnology, Taipei 251, Taiwan.

j To whom all correspondence should be addressed: Institute of Microbiology and Immunology, National Yang-Ming University, Shih-Pai, Taipei 11221, Taiwan. Tel.: 886-2-28267161; Fax: 886-2-28212880; E-mail: slhsieh@ym.edu.tw.

k Supported by Precursory Research for Embryonic Science and Technology, Japan Science and Technology Corporation, and a grant from Human Frontier Science Program.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
L. A. Madge, M. S. Kluger, J. S. Orange, and M. J. May
Lymphotoxin-{alpha}1{beta}2 and LIGHT Induce Classical and Noncanonical NF-{kappa}B-Dependent Proinflammatory Gene Expression in Vascular Endothelial Cells
J. Immunol., March 1, 2008; 180(5): 3467 - 3477.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Yang, N. ud Din, D. D. Browning, S. I. Abrams, and K. Liu
Targeting Lymphotoxin {beta} Receptor with Tumor-Specific T Lymphocytes for Tumor Regression
Clin. Cancer Res., September 1, 2007; 13(17): 5202 - 5210.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M.-J. Hsu, C. Y. Hsu, B.-C. Chen, M.-C. Chen, G. Ou, and C.-H. Lin
Apoptosis Signal-Regulating Kinase 1 in Amyloid {beta} Peptide-Induced Cerebral Endothelial Cell Apoptosis
J. Neurosci., May 23, 2007; 27(21): 5719 - 5729.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Lukashev, D. LePage, C. Wilson, V. Bailly, E. Garber, A. Lukashin, A. Ngam-ek, W. Zeng, N. Allaire, S. Perrin, et al.
Targeting the Lymphotoxin-{beta} Receptor with Agonist Antibodies as a Potential Cancer Therapy
Cancer Res., October 1, 2006; 66(19): 9617 - 9624.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-I. You, M.-C. Chen, H.-W. Wang, Y.-C. Chou, C.-H. Lin, and S.-L. Hsieh
Inhibition of Lymphotoxin-{beta} Receptor-Mediated Cell Death by Survivin-{Delta}Ex3.
Cancer Res., March 15, 2006; 66(6): 3051 - 3061.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.